ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: May. 15, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 15, 2026 | CORRESP | Neutral/Informational | High | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-3. They are seeking to have the statement dec… | Read Filing EDGAR |
| May. 11, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Artelo Biosciences, Inc. that it will not review their registration statement filed on May 4, 2026. The letter emphasizes that the responsibility for t… | Read Filing EDGAR |
| Apr. 13, 2026 | CORRESP | Neutral/Informational | High | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-1. They are seeking to have the statement dec… | Read Filing EDGAR |
| Apr. 13, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated April 13, 2026, informs Gregory D. Gorgas, CEO of Artelo Biosciences, Inc., that the SEC has not reviewed and will not review their registration state… | Read Filing EDGAR |
| Mar. 25, 2026 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC to accelerate the effectiveness of their Registration Statement on Form S-1. They are seeking to have the registration … | Read Filing EDGAR |
| Mar. 20, 2026 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effectiveness of their Registration Statement on Form S-1. They a… | Read Filing EDGAR |
| Mar. 20, 2026 | CORRESP | Neutral/Informational | Moderate | The correspondence from Craft Capital Management LLC to the SEC pertains to Artelo Biosciences, Inc.'s request for the acceleration of the effective date of their Registration Sta… | Read Filing EDGAR |
| Mar. 13, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Artelo Biosciences, Inc. that it does not intend to review the company's draft registration statement submitted on March 9, 2026. The SEC has requested… | Read Filing EDGAR |
| Dec. 1, 2025 | CORRESP | Neutral/Informational | Moderate | Artelo Biosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective on December 2, … | Read Filing EDGAR |